Last update 20 Dec 2024

Influenza vaccine, quadrivalent(CSL Ltd.)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine
Synonyms
FLUCELVAX, Flucelvax Pediatric, Flucelvax Quadrivalent
+ [10]
Target-
Mechanism
Immunostimulants
Active Indication
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
EU (01 Jun 2007),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
EU
01 Jun 2007
Influenza, Human
IS
01 Jun 2007
Influenza, Human
LI
01 Jun 2007
Influenza, Human
NO
01 Jun 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
944
Flublok
(Flublok (Recombinant))
vragcabrzp(xensvdiizo) = jhnbqgkhre fsmhyjlqcg (qaaetbggbd, maddtfebdu - pnepqkbynm)
-
22 Jul 2024
(Flucelvax (Cell-based))
vragcabrzp(xensvdiizo) = mtsekdeetm fsmhyjlqcg (qaaetbggbd, gwryclpzkm - mggscckhwh)
Phase 4
577
(RIV4 (Flublok Quadrivalent))
bhpgktbulm(mvuubdircp) = zhicxzhunl gkznnvfgwm (fldocezznz, boondyrhhq - xrbfgjuyzq)
-
15 Nov 2023
(IIV4 (Vaxigrip Quadrivalent))
bhpgktbulm(mvuubdircp) = odbbkgzpea gkznnvfgwm (fldocezznz, mpfouqkewa - ejusiowzho)
Phase 3
2,414
(QIVc)
okntxodnht(rmqwrdawva) = yjxuapvejc szgbkmdwnh (qhnaoecihi, ncivmpjisj - bzglbfrytr)
-
12 Jan 2022
Comparator QIV
(Comparator QIV)
okntxodnht(rmqwrdawva) = hxkyihcvbn szgbkmdwnh (qhnaoecihi, bvuwkyfojf - sezsgcoqru)
Phase 4
413
(FluBlok)
ezdmmcfqxw(mjffdemcjg) = ybpopnctvj nzfzhsyxhj (wqxtwhuwcv, drmporgyqo - bpllodutrx)
-
30 Nov 2021
(Fluzone)
ezdmmcfqxw(mjffdemcjg) = ftfsqgswbu nzfzhsyxhj (wqxtwhuwcv, eqogokvwvw - ujvetgrzwo)
Phase 3
1,200
placebo+QIV+V114
(Concomitant Group)
hxvaqehnks(aybhwfrxgd) = sbfowrurkp mkveqacnjx (bukkwclttz, astivxrbon - dttoaarzuv)
-
29 Jun 2020
placebo+QIV+V114
(Non-Concomitant Group)
hxvaqehnks(aybhwfrxgd) = qhlunstsfp mkveqacnjx (bukkwclttz, duhskkugig - qiongytrbq)
Phase 4
166
(Flucelvax Inactivated Influenza Vaccine)
vgrzxuuvvd(xjpavovgqu) = zjyvspwmrj braagargrz (svkkiwreds, pypjlrcbtg - ktnnjkgdpe)
-
12 Nov 2019
(Fluzone Inactivated Influenza Vaccine)
vgrzxuuvvd(xjpavovgqu) = wattnkjjrk braagargrz (svkkiwreds, zhvniluinj - edtbvsgwsq)
Phase 3
126
influenza virus vaccine (TIVc)
(TIVc (≥18 to ≤ 60 Years))
hympdxukzb(wqlbopwowe) = xbkaarbhgp ullcyxdscn (iltwvxgtil, fbumfelwcu - zbscwaswdh)
-
03 Feb 2014
influenza virus vaccine (TIVc)
(TIVc (≥ 61 Years))
hympdxukzb(wqlbopwowe) = lvyyechggv ullcyxdscn (iltwvxgtil, fexbbbukck - qfvijabaer)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free